InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
33%
T+90 mean return
-19.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Hicks Derek, Executive. Director active across 1 company, notably Intellia Therapeutics, Inc.. In total, 6 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €245k. History available since 3 January 2022. The latest transaction was disclosed on 3 January 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hicks Derek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6,502 shares@ US$12.1831.4% of flowCommon StockSEC:0000950170-25-003014:0
29,393 shares0Common StockSEC:0000950170-24-025903:0
3,877 shares@ US$29.4642.5% of flowCommon StockSEC:0000950170-24-002507:0
23,558 shares0Common StockSEC:0001209191-23-015817:0
1,812 shares@ US$37.2126.0% of flowCommon StockSEC:0001209191-23-002421:0
19,118 shares0Common StockSEC:0001209191-22-001651:0
6 of 6 declarations
About Hicks Derek
Derek Hicks is the Executive Vice President and Chief Business Officer at Intellia Therapeutics, Inc. He oversees business operations and contributes to the company's development strategy. His role is essential in achieving growth objectives.
